Vicarious Surgical (RBOT) Debt Ratio (2021 - 2022)

Vicarious Surgical's (RBOT) quarterly Debt Ratio came in at 0.0 in Q3 2022, down 61.62% year-on-year from 0.0 in Q3 2021, and down 30.56% on a QoQ basis from 0.0 in Q2 2022.

Vicarious Surgical (RBOT) Debt Ratio (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOT) has 2 years of Debt Ratio data on file, last reported at 0.0 in Q3 2022.

  • On a quarterly basis, Debt Ratio fell 61.62% year-over-year to 0.0 in Q3 2022; TTM through Sep 2022 was 0.0, a 61.62% decrease from a year earlier, with the FY2021 full-year figure at 0.0, changed N/A from the prior year.
  • Debt Ratio for Q3 2022 stood at 0.0, down from 0.0 in the prior quarter.
  • Over the last five years, Debt Ratio for RBOT reached as high as 0.0 in Q3 2021 and fell as low as 0.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.31
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.32
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.30
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.04
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.30
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.27
9 Smith & Nephew 25.80 Bn 25.22 Bn - 0.30
10 Vicarious Surgical 654,984.55 -9.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00